A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer

  • Gurney, Howard (Primary Chief Investigator)
  • Cunningham, Jacob (Chief Investigator)

Project: Other

Project Details

StatusActive
Effective start/end date4/04/193/04/24